Immunocore Secures $130 Million Series B Financing
Immunocore Secures $130 Million Series B Financing Led by General Atlantic, funding will expand novel scientific platform and advance proprietary pipeline of ImmTAX™ molecules into the clinic (Oxfordshire, UK and Conshohocken, Pa. and Rockville, Md., US, 2 …